Primer-Like Inhibitors for DNA Repair Enzymes of the AML-HL60 and WERI-1A/Y79 Malignant Cells

S. V. Stovbun, K. Ermakov, A. Bukhvostov, A. S. Vedenkin, D. Kuznetsov
{"title":"Primer-Like Inhibitors for DNA Repair Enzymes of the AML-HL60 and WERI-1A/Y79 Malignant Cells","authors":"S. V. Stovbun, K. Ermakov, A. Bukhvostov, A. S. Vedenkin, D. Kuznetsov","doi":"10.4236/aer.2019.73003","DOIUrl":null,"url":null,"abstract":"A conventionally synthesized thio- and cyano-modified \nsingle-stranded poly(dNTP) sequences of different molecular sizes \n(20n - 200n) and the same lengths routine poly(dNTP) and poly(NTP) species were \nobtained through the good services provided \nby the Russian Federal Bioorganic Products Group and by the \nThermoFischer, Inc., and then tested for their impact on catalytic activities \nof β-like DNA polymerases from chromatin of HL-60, WERI-1A and Y-79 cells as well as for the affinity patterns in \nDNApolβ-poly(dNTP)/ (NTP) pairs, respectively. An essential link between the lengths of \nultrashort (50n - 100n) single-stranded poly(dNTP) sequences of different structures and their \ninhibitory effects towards the cancer-specific DNA polymerases β has been found. A possible significance of this phenomenon for both DNA \nrepair suppression in tumors and a consequent anti-cancer activity of the DNA \nrepair related short poly(dNTP) fragments has been for the first time \nemphasized with a respect to their pharmacophore revealing potential. Thus, \nthis work presents an experimental attempt to upgrade a contemporary attitude \ntowards the DNA derived products applied for anti-cancer agenda, particularly, for acute myeloid leukemia and \nretinoblastoma cell DNA repair machinery breakdown. In this study, tumor \nspecific DNA polymerases β were found \nof being the targets for attack promoted with the primer-like single-stranded DNA fragments followed by consequent \ncytostatic phenomena. A novel concept of the DNA related anti-cancer medicines \nis under discussion.","PeriodicalId":65616,"journal":{"name":"酶研究进展(英文)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"酶研究进展(英文)","FirstCategoryId":"1089","ListUrlMain":"https://doi.org/10.4236/aer.2019.73003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

A conventionally synthesized thio- and cyano-modified single-stranded poly(dNTP) sequences of different molecular sizes (20n - 200n) and the same lengths routine poly(dNTP) and poly(NTP) species were obtained through the good services provided by the Russian Federal Bioorganic Products Group and by the ThermoFischer, Inc., and then tested for their impact on catalytic activities of β-like DNA polymerases from chromatin of HL-60, WERI-1A and Y-79 cells as well as for the affinity patterns in DNApolβ-poly(dNTP)/ (NTP) pairs, respectively. An essential link between the lengths of ultrashort (50n - 100n) single-stranded poly(dNTP) sequences of different structures and their inhibitory effects towards the cancer-specific DNA polymerases β has been found. A possible significance of this phenomenon for both DNA repair suppression in tumors and a consequent anti-cancer activity of the DNA repair related short poly(dNTP) fragments has been for the first time emphasized with a respect to their pharmacophore revealing potential. Thus, this work presents an experimental attempt to upgrade a contemporary attitude towards the DNA derived products applied for anti-cancer agenda, particularly, for acute myeloid leukemia and retinoblastoma cell DNA repair machinery breakdown. In this study, tumor specific DNA polymerases β were found of being the targets for attack promoted with the primer-like single-stranded DNA fragments followed by consequent cytostatic phenomena. A novel concept of the DNA related anti-cancer medicines is under discussion.
AML-HL60和WERI-1A/Y79恶性细胞DNA修复酶的引物样抑制剂
通过俄罗斯联邦生物有机产品集团和ThermoFischer, Inc.提供的良好服务,获得了不同分子大小(20n - 200n)和相同长度的常规聚(dNTP)和多聚(NTP)物种的常规合成硫和氰修饰单链多聚(dNTP)序列,然后测试了它们对HL-60染色质β样DNA聚合酶的催化活性的影响。对WERI-1A和Y-79细胞以及dna β-poly(dNTP)/ (NTP)对的亲和模式进行了研究。不同结构的超短(50n - 100n)单链多聚(dNTP)序列长度与它们对癌症特异性DNA聚合酶β的抑制作用之间存在重要联系。这一现象在肿瘤DNA修复抑制和DNA修复相关的短聚片段(dNTP)的抗癌活性方面的可能意义首次被强调,其药效团揭示潜力。因此,这项工作提出了一个实验尝试,以提升当代对用于抗癌议程的DNA衍生产品的态度,特别是用于急性髓性白血病和视网膜母细胞瘤细胞DNA修复机制故障。在这项研究中,肿瘤特异性DNA聚合酶β被发现是由类似引物的单链DNA片段促进的攻击目标,随后出现细胞抑制现象。DNA相关抗癌药物的新概念正在讨论中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
34
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信